Click to hear Dr Baglin's perspective on the role of the laboratory in treatment with new oral
anticoagulants Summary One of the key benefits of the direct oral anticoagulants (DOACs) is …

Direct oral anticoagulants (DOACs) have significantly improved the care of patients requiring
anticoagulation. With similar or better efficacy and safety outcomes and easier use in the …

This guidance document was prepared on behalf of the International Council for
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …

In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …

Direct oral anticoagulants (DOACs) are increasingly used in the treatment and prophylaxis
of thromboembolism because of several advantages over vitamin K antagonists, including …

Background: Oral anti-Xa inhibitors have demonstrated noninferiority to vitamin K
antagonists (VKAs) for the prevention of stroke in patients with atrial fibrillation and recurrent …

Background Applying a single anti-Xa assay, calibrated to unfractionated heparin to
measure rivaroxaban, apixaban, and edoxaban would simplify laboratory procedures and …

Background Central venous catheters are prone to clotting, particularly in patients with
cancer. Although low-molecular-weight heparin and direct oral anticoagulants, such as …

For more than a decade, US laboratories have failed to implement solutions to help their
clinicians in managing complex situations or patients on direct oral anticoagulants (DOACs) …

Abstract Purpose of Review The introduction of newer anticoagulants requires clinicians to
fully appreciate, interpret, and correctly apply the use of coagulation assays, such as the …